BATS & Imperial Brands (IMB): 2 cigarette stocks to buy now

3 min read | October 29, 2021 09:10 AM BST | By Nidhi Gupta

Highlights

  • Medicines and Healthcare products Regulatory Agency (MHRA) approved the use of e-cigarettes to be prescribed by doctors.
  • Recently, British American Tobacco received US Food and Drug Administration (FDA) approval for its e-cigarette Vuse and flavoured nicotine pods.
  • Imperial Brands recommended a dividend of 42.12 pence per share for the half-year period ended 31 March 2021.

England-based Medicines and Healthcare products Regulatory Agency (MHRA) approved the use of e-cigarettes to be prescribed by doctors. The updated guidance approves medicinally licensed e-cigarettes as a prescription medicine for people who want to give up smoking. This is the first of its kind approval in any country to aid people to quit tobacco smoking. About 7% of the total adult population in Britain are considered to use e-cigarettes.

The manufacturers will be able to file for regulatory checks and approvals for the use of e-cigarettes by the National Health Service (NHS). Although smoking rates have declined to record low figures in Britain, it resulted in the death of about 64,000 people in England in 2019. The Ministry has also issued a warning that states regulated e-cigarettes are not risk-free but are less harmful than smoking tobacco.

Rising interest in e-cigarettes will prompt key cigarette and tobacco companies to diversify into manufacturing vaping products. British American Tobacco has recently received FDA approval for its e-cigarettes.

Below is a detailed review of the investment prospect in two FTSE-listed, dividend-paying cigarette stocks - British American Tobacco and Imperial Brands.

British American Tobacco & Imperial Brands: Market cap & Dividend

(Data source: EODHD/Others & company release)

British American Tobacco Plc (LON: BATS)

British American Tobacco is an FTSE 100 listed firm engaged in manufacturing and selling tobacco, cigarettes, and other nicotine products. Recently, British American Tobacco received US Food and Drug Administration (FDA) approval for its e-cigarette Vuse and flavoured nicotine pods that would be used along with it.

The shares of British American Tobacco closed at GBX 2,584.50, down by 0.58% on Thursday, 28 October 2021. The market cap of the company currently stands at £59,649.49 million.

British American Tobacco’s revenue was £12,175 million in H1 ended 30 June 2021, down by 0.8% year-on-year. Its operating profit was £4,907 million in the same period, representing a 3.7% decline year-on-year.

British American Tobacco announced an interim dividend of 215.6 pence per share, payable in equal quarterly equal instalments.

Imperial Brands Plc (LON: IMB)

Imperial Brands is a tobacco company engaged in manufacturing, marketing, and selling cigars, cigarettes, pipes and smokeless tobacco, etc.

The shares of Imperial Brands closed at GBX 1,553.50, down by 1.83% on Thursday, 28 October 2021. The market cap of the company currently stands at £14,976.91 million.

For the half-year ended 31 March 2021, Imperial Brands revenue rose by 6.1% year-on-year to £15,568 million compared to £14,672 million in 2020. Its operating profit was £1,637 million, fuelled by the disposal of the Premium Cigar division.

Imperial Brands recommended a dividend of 42.12 pence per share for the half-year period ended 31 March 2021, up from the previous year’s 41.70 pence per share.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (Kalkine Media, we or us) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalised advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.


Sponsored Articles


Investing Ideas

Previous Next